Dr. Karen DeSalvo stepped down last month as chief of the Office of the National Coordinator for Health Information Technology. DeSalvo recently spoke with Modern Healthcare about her nearly three years leading the ONC, which made her the longest-serving person in that role.
Florida lawmakers have pushed for an emergency session, as have some Democrats in Connecticut and Democratic presidential nominee Hillary Clinton's running mate, Sen. Tim Kaine of Virginia.
Don't hold your breath waiting for members of Congress to return to Washington to deal with the immediate public health threat posed by the Zika virus. That would require putting the public interest over politics, an approach gone missing in action during this poisonous election year.
Despite policy and technological innovation occurring nationwide, “Healthcare Nirvana”—better outcomes, cost effectiveness and health equity—remains unrealized. It is time to invest in a better healthcare future for all.
U.S. Solicitor General Donald Verrilli—who defended the Affordable Care Act in several major Supreme Court cases—will step down as of June 24. His principal deputy, Ian Gershengorn, will replace him as acting solicitor general.
Democrats are pressing top Senate Republicans to stop dragging their feet and act immediately on President Barack Obama's request for $1.9 billion to combat the Zika virus.
Companies vying to produce a Zika virus vaccine are in a race against time while there's still a large enough population of infected cases to test.
The nation's top health officials told lawmakers on Wednesday that efforts to combat the spread of Zika would be severely hindered if they reject President Barack Obama's request for $1.9 billion in emergency funding. They also said any diversion of Ebola funds would set back work in West Africa.
Data Points for the week of Dec. 14, 2015, covered the following topics: Mass shootings, healthcare costs, ebola, contraceptive coverage and breast cancer screening
Cheers erupted and people danced in the streets Saturday as Sierra Leone marked the end of the Ebola outbreak within its borders, although neighboring Guinea still struggles to stamp out the deadly virus that has killed more than 11,000 mostly in West Africa.
Leaders often talk about workplace culture, but it's hard to put a finger on what it means, or how it's developed.It comes from the people hired and the way they're treated, but it's also something leaders have to cultivate.
Johnson & Johnson has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study being conducted in that nation's Kambia district, where some of the country's most recent Ebola cases have been reported.